Lily Hechtman is professor of psychiatry and pediatrics and director of research, Division of Child Psychiatry, McGill University, Montreal Children's Hospital, 1001 Decarie Boulevard, Room A04.4205, Montreal, Quebec, Canada.
Considerations in selecting pharmacological treatments for attention deficit hyperactivity disorder Subscription
Attention deficit hyperactivity disorder (ADHD) is highly prevalent and is associated with significant impairment across the lifespan. Medication treatments, particularly stimulant medications, are important in the management of ADHD, although non-medication treatments (e.g. therapy to improve organisational, social and emotional regulation skills) are often also needed. The stimulant medications have a high response rate and improve the core symptoms of the disorder, but they are associated